|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/485 | |
| A61K 31/496 | |||
| A61P 25/30 | |||
| A61P 25/32 |
| (11) | Number of the document | 3134090 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15723775.1 |
| Date of filing the European patent application | 2015-04-22 | |
| (97) | Date of publication of the European application | 2017-03-01 |
| (45) | Date of publication and mention of the grant of the patent | 2019-06-05 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/JP2015/062913 |
| Date | 2015-04-22 |
| (87) | Number | WO 2015/163486 |
| Date | 2015-10-29 |
| (30) | Number | Date | Country code |
| 2014088148 | 2014-04-22 | JP |
| (72) |
MAEDA, Kenji, JP
NAKAMURA, Mai, JP
|
| (73) |
H. Lundbeck A/S,
Ottiliavej 9, 2500 Valby,
DK
Otsuka Pharmaceutical Co., Ltd., 2-9, Kanda Tsukasa-machi Chiyoda-ku, Tokyo 101-8535, JP |
| (54) | COMBINATION OF BREXPIPRAZOLE AND NALMEFENE AND USE THEREOF FOR TREATING SUBSTANCE-RELATED DISORDERS |
| COMBINATION OF BREXPIPRAZOLE AND NALMEFENE AND USE THEREOF FOR TREATING SUBSTANCE-RELATED DISORDERS |